AMICUS THERAPEUTICS, INC. company info

CIK 1178879
IRS Number 200422823
State of incorporation DE
Business address 1 CEDAR BROOK DRIVE
None
CRANBURY
NJ
08512
Mail address 1 CEDAR BROOK DRIVE
None
CRANBURY
NJ
08512

Short summary

AMICUS THERAPEUTICS, INC. is a New Jersey company, with head office located at 1 Cedar Brook Drive Cranbury, New Jersey 08512. In 2018 the company owned a total of 764.70 million USD worth of assets, including 483.05 million USD worth of current assets. 2016 was the year when the company amassed the most assets.

AMICUS THERAPEUTICS, INC. Income Statement

Name [in Millions USD]200120022003200420052006200720082009201020112012201320142015201620172018Trends
Revenue, Net 64.360.9221.4318.410.361.224.9636.93
Cost of Goods and Services Sold 0.836.2414.40
Gross Profit 1.224.1330.6976.84
Selling, General and Administrative Expense 20.7247.2771.1588.67127.20
Operating Expenses 71.7156.7672.3271.3464.5469.93130.44186.02472.68405.62
Operating Income (Loss) -7.35-55.84-50.89-52.93-64.18-68.70-130.44-181.89-441.99-328.78
Interest expense 0.280.260.150.090.051.481.585.4017.2422.40
Investment Income, Interest and Dividend 0.020.03
Other Nonoperating Income (Expense) 0.061.280.070.02-0.08-0.08-4.796.01-5.63
Income Tax Expense (Benefit) -1.14-3.63-3.25-3.51-1.11-3.74-165.12-0.09
Net income -6.77-8.81-19.97-46.35-41.17-39.36-6.57-54.94-44.41-48.79-59.63-68.93-132.12-200.04-284.00-349.00

AMICUS THERAPEUTICS, INC. Balance Sheet

Name [in Millions USD]200120022003200420052006200720082009201020112012201320142015201620172018Trends
Cash and cash equivalents 028.0724.6225.7928.8623.4841.90249.0263.6637.3973.3196.30
Available-for-sale Securities, Current 57.2666.9150.7036.09112.40150.49189.84309.50
Accounts Receivable, Net, Current 3.7915.0822.96
Inventories 0.193.957.778.17
Property, Plant and Equipment, Gross 11.9513.5314.0914.3319.5322.3121.5827.05
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 8.967.669.3210.7812.3814.2813.9514.4215.79
Goodwill 11.6111.61197.80197.80197.80197.80
Available-for-sale Securities, Noncurrent 2.8015.4315.11
Intangible Assets, Net (Excluding Goodwill) 2323486.70486.702323
Other Assets, Noncurrent 0.270.440.440.520.921.663.015.9211.27
Total assets 90.29111.6082.34117.99403.91914.01938.97825.89764.70
Current assets 88.10105.6777.1879.42365.00217.67240.99576.23483.05
Accounts payable 2.582.122.155.8716.4812.917.876.61
Total current liabilities 16.8817.819.9711.1716.9080.46100.6852.9665.87
Deferred Revenue, Noncurrent 22.3215.68
Deferred income taxes 9.19176.22173.876.47
Total liabilities 263.99313.03
Common Stock, Value, Issued 0.410.520.560.791.241.401.491.942.35
Retained Earnings (Accumulated Deficit) -251.68-292.58-351.70-409.08-498.87-674.31-882.74-1,174.98-1,532.52
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.010.020.00-0.00-0.050.05

AMICUS THERAPEUTICS, INC. Cash Flow

Name [in Millions USD]200120022003200420052006200720082009201020112012201320142015201620172018Trends
Net income -6.77-8.81-19.97-46.35-41.17-39.36-6.57-54.94-44.41-48.79-59.63-68.93-132.12-200.04-284.00-349.00
Depreciation and amortization 2.132.061.591.711.721.551.83
Depreciation 1.551.833.243.594.22
Accounts receivable 1.427.7313.29
Inventories 3.650.904.21
Deferred revenue -47.7432.28-4.78
Net Cash Provided by (Used in) Operating Activities -43.37-13.98-49.42-100.14-150.15-215.49-299.96
Payments to Acquire Property, Plant, and Equipment 1.810.381.424.320.700.244.825.954.536.31
Payments to Acquire Businesses, Net of Cash Acquired 141.06
Net Cash Provided by (Used in) Investing Activities 31.87-19.4446.45-145.34-4.51-171.24-121.20
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -19.4446.45-39.4326.08-107.08-145.34-4.51
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 2.823.826.457.796.198.686.196.186.019.9717.5023.1029.26
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 2.823.826.457.796.198.686.196.186.019.9717.5023.1029.26
Proceeds from Issuance of Common Stock 45.2180.2015135.81243.0497.07243.04294.58
Net Cash Provided by (Used in) Financing Activities 2.7743.66-0.93290.89272.72247.43450.78
Cash and Cash Equivalents, Period Increase (Decrease) -8.7310.23-3.90-19.5745.41117.54-137.97